Prices delayed by at least 15 minutes | Print
Ondine Biomedical Inc. (OBI)
COM SHS NPV (CDI)Open
9.25p
Previous close
9.25p
Trade high
9.26p
Volume
900
Year high
13.30p
Year low
5.00p
Dividend yield
–
Market capitalisation
£41.04 mn
P/E ratio
–
ISIN
CA68234M2058
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportableoperating segment that is antimicrobial photodynamic therapy (aPDT) products.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 29/04/2025 | 08:18:13 | 9.26 | 900 | 83.34 |
| 28/04/2025 | 08:43:16 | 9.27 | 100,000 | 9,270.00 |
| 25/04/2025 | 08:03:17 | 9.28 | 5,323 | 493.97 |
| 24/04/2025 | 08:09:14 | 9.133 | 2,500 | 228.32 |
| 23/04/2025 | 11:30:24 | 9.3 | 152 | 14.14 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.